Extraordinary General Meeting 2020
The Extraordinary General Meeting of Oncopeptides AB (publ) was held on Friday 4 December 2020. Due to the extraordinary situation resulting from the covid-19 pandemic, Oncopeptides’ Extraordinary General Meeting was carried out through advance voting (postal voting) pursuant to temporary legislation. Hence, the Extraordinary General Meeting was held without physical presence.
The minutes together with other documents related to the EGM can be found below.
Documents
-
Minutes from the EGM 2020PDF, 1.5 MB
-
Bulletin EGM 2020PDF, 0.1 MB
-
Notice to EGM 2020 i Oncopeptides AB (publ)PDF, 0.2 MB
-
Notification of Attendance and form for Advance Voting - EGM 2020PDF, 0.3 MB
-
Power of Attorney form - EGM 2020PDF, 0.1 MB
-
Complete proposal item 7 - long term incentive program for employees in USPDF, 0.4 MB
-
Oncopeptides AB - Auditor statementPDF, 0.0 MB
-
Oncopeptides - Board statementPDF, 1.3 MB
-
Interim Report Q3 2020PDF, 1.0 MB
-
Annual Report 2019PDF, 4.4 MB